ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Intestinal Anti-infective Drugs Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-23W17682
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Intestinal Anti infective Drugs Market Research Report 2024
BUY CHAPTERS

Global Intestinal Anti-infective Drugs Market Research Report 2024

Code: QYRE-Auto-23W17682
Report
August 2024
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Salix Pharmaceuticals
Hubei Hendi Pharmaceutical Co., Ltd.
Jiangxi Pharmaceutical Co., Ltd.
Botanic Healthcare
Medikonda Nutrients
VOX NUTRITION
Advacare Pharma
Otto Chemie Pvt. Ltd.
Teva Pharmaceuticals
Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
Jilin Fukang Pharmaceutical Co., Ltd.
Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
Shandong Xinhua Pharmaceutical Co Ltd
Yunnan Weihe Pharmaceutical Co., Ltd.
Tiansheng Pharmaceutical Group Co.,Ltd
Jilin Jibang Pharmaceutical Co., Ltd.
Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
Chongqing Sino Biopharmaceutical Co., Ltd.
Yangzhou Sanyao Pharmaceutical Co., Ltd.
Chongqing Laimi Pharmaceutical Co., Ltd.
Nanjing Chengong Pharmaceutical Co., Ltd.
Hainan Hailing Chemical Pharmaceutical Co., Ltd.
Teyi Pharmaceutical Group Co.,Ltd.
Sichuan Ziligong Pharmaceutical Co., Ltd.
Lingyuan Pharmaceutical Co., Ltd.
Zhejiang Deer Pharmaceutical Co., Ltd.

Intestinal Anti-infective Drugs Market

The global Intestinal Anti-infective Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Intestinal Anti-infective Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Intestinal Anti-infective Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Intestinal Anti-infective Drugs include Botanic Healthcare, Medikonda Nutrients, Vox Nutrition, AdvaCare Pharma, Otto Chemie Pvt Ltd, Teva Pharmaceuticals, Salix Pharmaceuticals, Hubei Hendi Pharmaceutical Co., Ltd., Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intestinal Anti-infective Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intestinal Anti-infective Drugs.
The Intestinal Anti-infective Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Intestinal Anti-infective Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intestinal Anti-infective Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intestinal Anti-infective Drugs Market Report

Report Metric Details
Report Name Intestinal Anti-infective Drugs Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Botanic Healthcare, Medikonda Nutrients, Vox Nutrition, AdvaCare Pharma, Otto Chemie Pvt Ltd, Teva Pharmaceuticals, Salix Pharmaceuticals, Hubei Hendi Pharmaceutical Co., Ltd., Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jilin Fukang Pharmaceutical Co., Ltd., Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd., Fujian Sanming Tiantai Pharmaceutical Co., Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., Sichuan Ziligong Pharmaceutical Co., Ltd., Yunnan Weihe Pharmaceutical Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd., Lingyuan Pharmaceutical Co., Ltd., Jilin Jibang Pharmaceutical Co., Ltd., Shaanxi Kaiyuan Pharmaceutical Co., Ltd., Chongqing Sino Biopharmaceutical Co., Ltd., Yangzhou Sanyao Pharmaceutical Co., Ltd., Chongqing Laimi Pharmaceutical Co., Ltd., Nanjing Chengong Pharmaceutical Co., Ltd., Hainan Hailing Chemical Pharmaceutical Co., Ltd., Zhejiang Deer Pharmaceutical Co., Ltd., Teyi Pharmaceutical Group Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Intestinal Anti-infective Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Intestinal Anti-infective Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Intestinal Anti-infective Drugs Market report?

Ans: The main players in the Intestinal Anti-infective Drugs Market are Botanic Healthcare, Medikonda Nutrients, Vox Nutrition, AdvaCare Pharma, Otto Chemie Pvt Ltd, Teva Pharmaceuticals, Salix Pharmaceuticals, Hubei Hendi Pharmaceutical Co., Ltd., Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd., Jiangxi Pharmaceutical Co., Ltd., Jilin Fukang Pharmaceutical Co., Ltd., Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd., Fujian Sanming Tiantai Pharmaceutical Co., Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., Sichuan Ziligong Pharmaceutical Co., Ltd., Yunnan Weihe Pharmaceutical Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd., Lingyuan Pharmaceutical Co., Ltd., Jilin Jibang Pharmaceutical Co., Ltd., Shaanxi Kaiyuan Pharmaceutical Co., Ltd., Chongqing Sino Biopharmaceutical Co., Ltd., Yangzhou Sanyao Pharmaceutical Co., Ltd., Chongqing Laimi Pharmaceutical Co., Ltd., Nanjing Chengong Pharmaceutical Co., Ltd., Hainan Hailing Chemical Pharmaceutical Co., Ltd., Zhejiang Deer Pharmaceutical Co., Ltd., Teyi Pharmaceutical Group Co., Ltd.

What are the Application segmentation covered in the Intestinal Anti-infective Drugs Market report?

Ans: The Applications covered in the Intestinal Anti-infective Drugs Market report are Hospital, Clinic, Pharmacy, Other

What are the Type segmentation covered in the Intestinal Anti-infective Drugs Market report?

Ans: The Types covered in the Intestinal Anti-infective Drugs Market report are Berberine, Rifaximin, Neomycin

Recommended Reports

Gastrointestinal Drugs

Infectious Disease Therapy

Diarrheal Disorder Markets

1 Intestinal Anti-infective Drugs Market Overview
1.1 Product Definition
1.2 Intestinal Anti-infective Drugs by Type
1.2.1 Global Intestinal Anti-infective Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Berberine
1.2.3 Rifaximin
1.2.4 Neomycin
1.3 Intestinal Anti-infective Drugs by Application
1.3.1 Global Intestinal Anti-infective Drugs Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global Intestinal Anti-infective Drugs Market Size Estimates and Forecasts
1.4.1 Global Intestinal Anti-infective Drugs Revenue 2019-2030
1.4.2 Global Intestinal Anti-infective Drugs Sales 2019-2030
1.4.3 Global Intestinal Anti-infective Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intestinal Anti-infective Drugs Market Competition by Manufacturers
2.1 Global Intestinal Anti-infective Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intestinal Anti-infective Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intestinal Anti-infective Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Intestinal Anti-infective Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intestinal Anti-infective Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intestinal Anti-infective Drugs, Product Type & Application
2.7 Global Key Manufacturers of Intestinal Anti-infective Drugs, Date of Enter into This Industry
2.8 Global Intestinal Anti-infective Drugs Market Competitive Situation and Trends
2.8.1 Global Intestinal Anti-infective Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Intestinal Anti-infective Drugs Players Market Share by Revenue
2.8.3 Global Intestinal Anti-infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Intestinal Anti-infective Drugs Market Scenario by Region
3.1 Global Intestinal Anti-infective Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intestinal Anti-infective Drugs Sales by Region: 2019-2030
3.2.1 Global Intestinal Anti-infective Drugs Sales by Region: 2019-2024
3.2.2 Global Intestinal Anti-infective Drugs Sales by Region: 2025-2030
3.3 Global Intestinal Anti-infective Drugs Revenue by Region: 2019-2030
3.3.1 Global Intestinal Anti-infective Drugs Revenue by Region: 2019-2024
3.3.2 Global Intestinal Anti-infective Drugs Revenue by Region: 2025-2030
3.4 North America Intestinal Anti-infective Drugs Market Facts & Figures by Country
3.4.1 North America Intestinal Anti-infective Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intestinal Anti-infective Drugs Sales by Country (2019-2030)
3.4.3 North America Intestinal Anti-infective Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intestinal Anti-infective Drugs Market Facts & Figures by Country
3.5.1 Europe Intestinal Anti-infective Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intestinal Anti-infective Drugs Sales by Country (2019-2030)
3.5.3 Europe Intestinal Anti-infective Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intestinal Anti-infective Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Intestinal Anti-infective Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intestinal Anti-infective Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Intestinal Anti-infective Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intestinal Anti-infective Drugs Market Facts & Figures by Country
3.7.1 Latin America Intestinal Anti-infective Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intestinal Anti-infective Drugs Sales by Country (2019-2030)
3.7.3 Latin America Intestinal Anti-infective Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intestinal Anti-infective Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Intestinal Anti-infective Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intestinal Anti-infective Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intestinal Anti-infective Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intestinal Anti-infective Drugs Sales by Type (2019-2030)
4.1.1 Global Intestinal Anti-infective Drugs Sales by Type (2019-2024)
4.1.2 Global Intestinal Anti-infective Drugs Sales by Type (2025-2030)
4.1.3 Global Intestinal Anti-infective Drugs Sales Market Share by Type (2019-2030)
4.2 Global Intestinal Anti-infective Drugs Revenue by Type (2019-2030)
4.2.1 Global Intestinal Anti-infective Drugs Revenue by Type (2019-2024)
4.2.2 Global Intestinal Anti-infective Drugs Revenue by Type (2025-2030)
4.2.3 Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Intestinal Anti-infective Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intestinal Anti-infective Drugs Sales by Application (2019-2030)
5.1.1 Global Intestinal Anti-infective Drugs Sales by Application (2019-2024)
5.1.2 Global Intestinal Anti-infective Drugs Sales by Application (2025-2030)
5.1.3 Global Intestinal Anti-infective Drugs Sales Market Share by Application (2019-2030)
5.2 Global Intestinal Anti-infective Drugs Revenue by Application (2019-2030)
5.2.1 Global Intestinal Anti-infective Drugs Revenue by Application (2019-2024)
5.2.2 Global Intestinal Anti-infective Drugs Revenue by Application (2025-2030)
5.2.3 Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Intestinal Anti-infective Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Botanic Healthcare
6.1.1 Botanic Healthcare Company Information
6.1.2 Botanic Healthcare Description and Business Overview
6.1.3 Botanic Healthcare Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Botanic Healthcare Intestinal Anti-infective Drugs Product Portfolio
6.1.5 Botanic Healthcare Recent Developments/Updates
6.2 Medikonda Nutrients
6.2.1 Medikonda Nutrients Company Information
6.2.2 Medikonda Nutrients Description and Business Overview
6.2.3 Medikonda Nutrients Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medikonda Nutrients Intestinal Anti-infective Drugs Product Portfolio
6.2.5 Medikonda Nutrients Recent Developments/Updates
6.3 Vox Nutrition
6.3.1 Vox Nutrition Company Information
6.3.2 Vox Nutrition Description and Business Overview
6.3.3 Vox Nutrition Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Vox Nutrition Intestinal Anti-infective Drugs Product Portfolio
6.3.5 Vox Nutrition Recent Developments/Updates
6.4 AdvaCare Pharma
6.4.1 AdvaCare Pharma Company Information
6.4.2 AdvaCare Pharma Description and Business Overview
6.4.3 AdvaCare Pharma Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AdvaCare Pharma Intestinal Anti-infective Drugs Product Portfolio
6.4.5 AdvaCare Pharma Recent Developments/Updates
6.5 Otto Chemie Pvt Ltd
6.5.1 Otto Chemie Pvt Ltd Company Information
6.5.2 Otto Chemie Pvt Ltd Description and Business Overview
6.5.3 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product Portfolio
6.5.5 Otto Chemie Pvt Ltd Recent Developments/Updates
6.6 Teva Pharmaceuticals
6.6.1 Teva Pharmaceuticals Company Information
6.6.2 Teva Pharmaceuticals Description and Business Overview
6.6.3 Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio
6.6.5 Teva Pharmaceuticals Recent Developments/Updates
6.7 Salix Pharmaceuticals
6.7.1 Salix Pharmaceuticals Company Information
6.7.2 Salix Pharmaceuticals Description and Business Overview
6.7.3 Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Salix Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolio
6.7.5 Salix Pharmaceuticals Recent Developments/Updates
6.8 Hubei Hendi Pharmaceutical Co., Ltd.
6.8.1 Hubei Hendi Pharmaceutical Co., Ltd. Company Information
6.8.2 Hubei Hendi Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.8.5 Hubei Hendi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
6.9.1 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information
6.9.2 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.9.5 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Jiangxi Pharmaceutical Co., Ltd.
6.10.1 Jiangxi Pharmaceutical Co., Ltd. Company Information
6.10.2 Jiangxi Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.10.5 Jiangxi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Jilin Fukang Pharmaceutical Co., Ltd.
6.11.1 Jilin Fukang Pharmaceutical Co., Ltd. Company Information
6.11.2 Jilin Fukang Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.11.5 Jilin Fukang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
6.12.1 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information
6.12.2 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.12.5 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
6.13.1 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Company Information
6.13.2 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.13.5 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Shandong Xinhua Pharmaceutical Co., Ltd.
6.14.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
6.14.2 Shandong Xinhua Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.14.5 Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Sichuan Ziligong Pharmaceutical Co., Ltd.
6.15.1 Sichuan Ziligong Pharmaceutical Co., Ltd. Company Information
6.15.2 Sichuan Ziligong Pharmaceutical Co., Ltd. Description and Business Overview
6.15.3 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.15.5 Sichuan Ziligong Pharmaceutical Co., Ltd. Recent Developments/Updates
6.16 Yunnan Weihe Pharmaceutical Co., Ltd.
6.16.1 Yunnan Weihe Pharmaceutical Co., Ltd. Company Information
6.16.2 Yunnan Weihe Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.16.5 Yunnan Weihe Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Tiansheng Pharmaceutical Group Co., Ltd.
6.17.1 Tiansheng Pharmaceutical Group Co., Ltd. Company Information
6.17.2 Tiansheng Pharmaceutical Group Co., Ltd. Description and Business Overview
6.17.3 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.17.5 Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.18 Lingyuan Pharmaceutical Co., Ltd.
6.18.1 Lingyuan Pharmaceutical Co., Ltd. Company Information
6.18.2 Lingyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.18.3 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.18.5 Lingyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.19 Jilin Jibang Pharmaceutical Co., Ltd.
6.19.1 Jilin Jibang Pharmaceutical Co., Ltd. Company Information
6.19.2 Jilin Jibang Pharmaceutical Co., Ltd. Description and Business Overview
6.19.3 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.19.5 Jilin Jibang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.20 Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
6.20.1 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information
6.20.2 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Description and Business Overview
6.20.3 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.20.5 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
6.21 Chongqing Sino Biopharmaceutical Co., Ltd.
6.21.1 Chongqing Sino Biopharmaceutical Co., Ltd. Company Information
6.21.2 Chongqing Sino Biopharmaceutical Co., Ltd. Description and Business Overview
6.21.3 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.21.5 Chongqing Sino Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.22 Yangzhou Sanyao Pharmaceutical Co., Ltd.
6.22.1 Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information
6.22.2 Yangzhou Sanyao Pharmaceutical Co., Ltd. Description and Business Overview
6.22.3 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.22.5 Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.23 Chongqing Laimi Pharmaceutical Co., Ltd.
6.23.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
6.23.2 Chongqing Laimi Pharmaceutical Co., Ltd. Description and Business Overview
6.23.3 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.23.5 Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.24 Nanjing Chengong Pharmaceutical Co., Ltd.
6.24.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
6.24.2 Nanjing Chengong Pharmaceutical Co., Ltd. Description and Business Overview
6.24.3 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.24.5 Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments/Updates
6.25 Hainan Hailing Chemical Pharmaceutical Co., Ltd.
6.25.1 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information
6.25.2 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Description and Business Overview
6.25.3 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.25.5 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments/Updates
6.26 Zhejiang Deer Pharmaceutical Co., Ltd.
6.26.1 Zhejiang Deer Pharmaceutical Co., Ltd. Company Information
6.26.2 Zhejiang Deer Pharmaceutical Co., Ltd. Description and Business Overview
6.26.3 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.26.4 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.26.5 Zhejiang Deer Pharmaceutical Co., Ltd. Recent Developments/Updates
6.27 Teyi Pharmaceutical Group Co., Ltd.
6.27.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
6.27.2 Teyi Pharmaceutical Group Co., Ltd. Description and Business Overview
6.27.3 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue and Gross Margin (2019-2024)
6.27.4 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolio
6.27.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intestinal Anti-infective Drugs Industry Chain Analysis
7.2 Intestinal Anti-infective Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intestinal Anti-infective Drugs Production Mode & Process
7.4 Intestinal Anti-infective Drugs Sales and Marketing
7.4.1 Intestinal Anti-infective Drugs Sales Channels
7.4.2 Intestinal Anti-infective Drugs Distributors
7.5 Intestinal Anti-infective Drugs Customers
8 Intestinal Anti-infective Drugs Market Dynamics
8.1 Intestinal Anti-infective Drugs Industry Trends
8.2 Intestinal Anti-infective Drugs Market Drivers
8.3 Intestinal Anti-infective Drugs Market Challenges
8.4 Intestinal Anti-infective Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Salix Pharmaceuticals
Hubei Hendi Pharmaceutical Co., Ltd.
Jiangxi Pharmaceutical Co., Ltd.
Botanic Healthcare
Medikonda Nutrients
VOX NUTRITION
Advacare Pharma
Otto Chemie Pvt. Ltd.
Teva Pharmaceuticals
Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
Jilin Fukang Pharmaceutical Co., Ltd.
Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
Shandong Xinhua Pharmaceutical Co Ltd
Yunnan Weihe Pharmaceutical Co., Ltd.
Tiansheng Pharmaceutical Group Co.,Ltd
Jilin Jibang Pharmaceutical Co., Ltd.
Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
Chongqing Sino Biopharmaceutical Co., Ltd.
Yangzhou Sanyao Pharmaceutical Co., Ltd.
Chongqing Laimi Pharmaceutical Co., Ltd.
Nanjing Chengong Pharmaceutical Co., Ltd.
Hainan Hailing Chemical Pharmaceutical Co., Ltd.
Teyi Pharmaceutical Group Co.,Ltd.
Sichuan Ziligong Pharmaceutical Co., Ltd.
Lingyuan Pharmaceutical Co., Ltd.
Zhejiang Deer Pharmaceutical Co., Ltd.
List of Tables
 Table 1. Global Intestinal Anti-infective Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Intestinal Anti-infective Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Intestinal Anti-infective Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Intestinal Anti-infective Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Intestinal Anti-infective Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Intestinal Anti-infective Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Intestinal Anti-infective Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Intestinal Anti-infective Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Intestinal Anti-infective Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Intestinal Anti-infective Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Intestinal Anti-infective Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Intestinal Anti-infective Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Intestinal Anti-infective Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intestinal Anti-infective Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Intestinal Anti-infective Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Intestinal Anti-infective Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Intestinal Anti-infective Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Intestinal Anti-infective Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Intestinal Anti-infective Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Intestinal Anti-infective Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Intestinal Anti-infective Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Intestinal Anti-infective Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Intestinal Anti-infective Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Intestinal Anti-infective Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Intestinal Anti-infective Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Intestinal Anti-infective Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Intestinal Anti-infective Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Intestinal Anti-infective Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Intestinal Anti-infective Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Intestinal Anti-infective Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Intestinal Anti-infective Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Intestinal Anti-infective Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Intestinal Anti-infective Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Intestinal Anti-infective Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Intestinal Anti-infective Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Intestinal Anti-infective Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Intestinal Anti-infective Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Intestinal Anti-infective Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Intestinal Anti-infective Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Intestinal Anti-infective Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Intestinal Anti-infective Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Intestinal Anti-infective Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Intestinal Anti-infective Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Intestinal Anti-infective Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Intestinal Anti-infective Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Intestinal Anti-infective Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Intestinal Anti-infective Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Intestinal Anti-infective Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Intestinal Anti-infective Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Intestinal Anti-infective Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Intestinal Anti-infective Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Intestinal Anti-infective Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Intestinal Anti-infective Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Intestinal Anti-infective Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Intestinal Anti-infective Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Intestinal Anti-infective Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Intestinal Anti-infective Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Intestinal Anti-infective Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Intestinal Anti-infective Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Intestinal Anti-infective Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Intestinal Anti-infective Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Intestinal Anti-infective Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Intestinal Anti-infective Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Intestinal Anti-infective Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Botanic Healthcare Company Information
 Table 71. Botanic Healthcare Description and Business Overview
 Table 72. Botanic Healthcare Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Botanic Healthcare Intestinal Anti-infective Drugs Product
 Table 74. Botanic Healthcare Recent Developments/Updates
 Table 75. Medikonda Nutrients Company Information
 Table 76. Medikonda Nutrients Description and Business Overview
 Table 77. Medikonda Nutrients Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Medikonda Nutrients Intestinal Anti-infective Drugs Product
 Table 79. Medikonda Nutrients Recent Developments/Updates
 Table 80. Vox Nutrition Company Information
 Table 81. Vox Nutrition Description and Business Overview
 Table 82. Vox Nutrition Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Vox Nutrition Intestinal Anti-infective Drugs Product
 Table 84. Vox Nutrition Recent Developments/Updates
 Table 85. AdvaCare Pharma Company Information
 Table 86. AdvaCare Pharma Description and Business Overview
 Table 87. AdvaCare Pharma Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. AdvaCare Pharma Intestinal Anti-infective Drugs Product
 Table 89. AdvaCare Pharma Recent Developments/Updates
 Table 90. Otto Chemie Pvt Ltd Company Information
 Table 91. Otto Chemie Pvt Ltd Description and Business Overview
 Table 92. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product
 Table 94. Otto Chemie Pvt Ltd Recent Developments/Updates
 Table 95. Teva Pharmaceuticals Company Information
 Table 96. Teva Pharmaceuticals Description and Business Overview
 Table 97. Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Teva Pharmaceuticals Intestinal Anti-infective Drugs Product
 Table 99. Teva Pharmaceuticals Recent Developments/Updates
 Table 100. Salix Pharmaceuticals Company Information
 Table 101. Salix Pharmaceuticals Description and Business Overview
 Table 102. Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Salix Pharmaceuticals Intestinal Anti-infective Drugs Product
 Table 104. Salix Pharmaceuticals Recent Developments/Updates
 Table 105. Hubei Hendi Pharmaceutical Co., Ltd. Company Information
 Table 106. Hubei Hendi Pharmaceutical Co., Ltd. Description and Business Overview
 Table 107. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 109. Hubei Hendi Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 110. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information
 Table 111. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Description and Business Overview
 Table 112. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 114. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. Jiangxi Pharmaceutical Co., Ltd. Company Information
 Table 116. Jiangxi Pharmaceutical Co., Ltd. Description and Business Overview
 Table 117. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 119. Jiangxi Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 120. Jilin Fukang Pharmaceutical Co., Ltd. Company Information
 Table 121. Jilin Fukang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 122. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 124. Jilin Fukang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 125. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information
 Table 126. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Description and Business Overview
 Table 127. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 129. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 130. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Company Information
 Table 131. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Description and Business Overview
 Table 132. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 134. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 135. Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
 Table 136. Shandong Xinhua Pharmaceutical Co., Ltd. Description and Business Overview
 Table 137. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 139. Shandong Xinhua Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 140. Sichuan Ziligong Pharmaceutical Co., Ltd. Company Information
 Table 141. Sichuan Ziligong Pharmaceutical Co., Ltd. Description and Business Overview
 Table 142. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 144. Sichuan Ziligong Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 145. Yunnan Weihe Pharmaceutical Co., Ltd. Company Information
 Table 146. Yunnan Weihe Pharmaceutical Co., Ltd. Description and Business Overview
 Table 147. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 149. Yunnan Weihe Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 150. Tiansheng Pharmaceutical Group Co., Ltd. Company Information
 Table 151. Tiansheng Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 152. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 154. Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 155. Lingyuan Pharmaceutical Co., Ltd. Company Information
 Table 156. Lingyuan Pharmaceutical Co., Ltd. Description and Business Overview
 Table 157. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 159. Lingyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 160. Jilin Jibang Pharmaceutical Co., Ltd. Company Information
 Table 161. Jilin Jibang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 162. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 164. Jilin Jibang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 165. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information
 Table 166. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Description and Business Overview
 Table 167. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 168. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 169. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 170. Chongqing Sino Biopharmaceutical Co., Ltd. Company Information
 Table 171. Chongqing Sino Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 172. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 173. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 174. Chongqing Sino Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 175. Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information
 Table 176. Yangzhou Sanyao Pharmaceutical Co., Ltd. Description and Business Overview
 Table 177. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 178. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 179. Yangzhou Sanyao Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 180. Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
 Table 181. Chongqing Laimi Pharmaceutical Co., Ltd. Description and Business Overview
 Table 182. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 183. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 184. Chongqing Laimi Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 185. Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
 Table 186. Nanjing Chengong Pharmaceutical Co., Ltd. Description and Business Overview
 Table 187. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 188. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 189. Nanjing Chengong Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 190. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information
 Table 191. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Description and Business Overview
 Table 192. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 193. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 194. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 195. Zhejiang Deer Pharmaceutical Co., Ltd. Company Information
 Table 196. Zhejiang Deer Pharmaceutical Co., Ltd. Description and Business Overview
 Table 197. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 198. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 199. Zhejiang Deer Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 200. Teyi Pharmaceutical Group Co., Ltd. Company Information
 Table 201. Teyi Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 202. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 203. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product
 Table 204. Teyi Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 205. Key Raw Materials Lists
 Table 206. Raw Materials Key Suppliers Lists
 Table 207. Intestinal Anti-infective Drugs Distributors List
 Table 208. Intestinal Anti-infective Drugs Customers List
 Table 209. Intestinal Anti-infective Drugs Market Trends
 Table 210. Intestinal Anti-infective Drugs Market Drivers
 Table 211. Intestinal Anti-infective Drugs Market Challenges
 Table 212. Intestinal Anti-infective Drugs Market Restraints
 Table 213. Research Programs/Design for This Report
 Table 214. Key Data Information from Secondary Sources
 Table 215. Key Data Information from Primary Sources
 Table 216. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Intestinal Anti-infective Drugs
 Figure 2. Global Intestinal Anti-infective Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Intestinal Anti-infective Drugs Market Share by Type: 2023 & 2030
 Figure 4. Berberine Product Picture
 Figure 5. Rifaximin Product Picture
 Figure 6. Neomycin Product Picture
 Figure 7. Global Intestinal Anti-infective Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Intestinal Anti-infective Drugs Market Share by Application: 2023 & 2030
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Pharmacy
 Figure 12. Other
 Figure 13. Global Intestinal Anti-infective Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Intestinal Anti-infective Drugs Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Intestinal Anti-infective Drugs Sales (2019-2030) & (K Units)
 Figure 16. Global Intestinal Anti-infective Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 17. Intestinal Anti-infective Drugs Report Years Considered
 Figure 18. Intestinal Anti-infective Drugs Sales Share by Manufacturers in 2023
 Figure 19. Global Intestinal Anti-infective Drugs Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Intestinal Anti-infective Drugs Players: Market Share by Revenue in Intestinal Anti-infective Drugs in 2023
 Figure 21. Intestinal Anti-infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Intestinal Anti-infective Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Intestinal Anti-infective Drugs Sales Market Share by Country (2019-2030)
 Figure 24. North America Intestinal Anti-infective Drugs Revenue Market Share by Country (2019-2030)
 Figure 25. United States Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Intestinal Anti-infective Drugs Sales Market Share by Country (2019-2030)
 Figure 28. Europe Intestinal Anti-infective Drugs Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Intestinal Anti-infective Drugs Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Intestinal Anti-infective Drugs Revenue Market Share by Region (2019-2030)
 Figure 36. China Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Intestinal Anti-infective Drugs Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Intestinal Anti-infective Drugs Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Intestinal Anti-infective Drugs Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Intestinal Anti-infective Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Intestinal Anti-infective Drugs by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Intestinal Anti-infective Drugs by Type (2019-2030)
 Figure 55. Global Intestinal Anti-infective Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Intestinal Anti-infective Drugs by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Intestinal Anti-infective Drugs by Application (2019-2030)
 Figure 58. Global Intestinal Anti-infective Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 59. Intestinal Anti-infective Drugs Value Chain
 Figure 60. Intestinal Anti-infective Drugs Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Anti infective Drugs for Animals Market Research Report 2024
Global Anti Infective Medications Market Research Report 2024
Global Anti Infective Therapy Market Research Report 2024
Global Medical Anti infective Agent Market Research Report 2025
Global Pediatric Gastrointestinal Drugs Market Research Report 2025
Global Gastrointestinal Motility Drugs Market Research Report 2024
Global Medication For Gastrointestinal Bleeding Market Research Report 2024
Global Microbial Antibacterial Drugs Market Research Report 2024
Infectious Enteritis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antiviral Microbial Drugs Market Research Report 2024
Global Antiinfective API Market Research Report 2024
Global Intestinal Cannulation Market Research Report 2024
Global Anti infectious Disease Drugs Market Research Report 2025
Intra abdominal Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Digestive System Drugs Market Research Report 2024
Global Intestinal Adsorbents Market Research Report 2024
Global Antidiarrheal Microorganisms Market Research Report 2024
Intestinal Ascariasis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intestinal Prescription Cat Food Market Research Report 2024
Chronic Intestinal Inflammation Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions